Jan. 8, 2026 — Siemens Healthineers has received Food and Drug Administration clearance for the 70 cm bore Magnetom Flow. platform, a 1.5 tesla (T) platform for magnetic resonance (MR) imaging with a closed helium circuit and no quench pipe, which reduces helium dependency and annual energy consumption.

Jan. 7, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has partnered with Jefferson Health, one of the largest academic health systems in the United States, in a clinical study to advance rapid incorporation of diagnostic-quality FoCUS echocardiogram workflows. The pilot is funded in part by the Israel Innovation Authority (IIA) through the Jefferson–Israel 2025 Health Tech Pilot Program, which provides Israeli companies with real-world clinical environments to evaluate new technologies, accelerate validation, and support successful entry into the U.S.

Dec. 31, 2025 – Carestream Health, Inc. has completed the separation of the company into two geographically focused organizations, enhancing the long-term growth potential of each company. As part of the separation, Carestream Health retained all of the company’s U.S. operations and most of the company’s international operations have been organized under Carestream Healthcare International Co. Ltd（previously known as Rayco (Shanghai) Medical Products Company Limited. In addition, Carestream International was acquired by affiliates of Midea Group Co., Ltd. as part of the transaction.

Jan. 6, 2026 — Butterfly Network, a provider of handheld, whole-body ultrasound and intuitive software, has announced plans to release its Beam Steering API for advanced third-party AI application and technology development within the company’s Butterfly Garden and Ultrasound-on-Chip co-development programs. The new API release, expected in the first half of 2026, will open access to core capabilities that were previously reserved for the company’s own app.

Jan. 6, 2026 — DirectMed Imaging, a portfolio company of Frazier Healthcare Partners, has acquired Tri-Imaging Solutions. DirectMed and Tri-Imaging will be combined into a single, integrated provider of aftermarket diagnostic imaging parts, systems, service, technical training and operate under the Tri-Imaging name.

Dec. 18, 2025 —  Brainomix, a provider of AI-powered imaging biomarkers for stroke and lung fibrosis, has announced results from its partnership with Argenica Therapeutics for imaging and clinical data analysis of the Phase II trial evaluating ARG-007, a neuroprotective agent for acute ischemic stroke.

Dec. 19, 2025 — Washington University in St. Louis (WashU) has been recognized as a Focused Ultrasound Center of Excellence (COE) by the Focused Ultrasound Foundation. This designation brings the university into a global community committed to advancing focused ultrasound technology for the benefit of patients. 

Dec. 16, 2025 — McCrae Tech has launched the world’s first health AI orchestrator called Orchestral. It is a health-native AI orchestrator data platform that seamlessly connects diverse data sources with AI agents, workflows and algorithms — enabling scalable, governed AI deployment across healthcare systems.  

"Most information technology in healthcare falls into two camps: either a big, dumb bucket of cloud data or isolated pockets of AI cleverness," said Ian McCrae, founder of McCrae Tech. "We have created something vastly different that reshapes healthcare as we know it."

Dec. 17, 2025 — The Harvey L. Neiman Health Policy Institute recently announced that three of its research articles have been recognized with prestigious awards from leading radiology journals for their impact on policy, education and practice management.

"Recognition from leading journals like JACR and AJR reinforces the importance of our mission to advance evidence-based decision-making in radiology," added Elizabeth Rula, PhD, Executive Director of the Neiman Institute.

Dec. 15, 2025 — Royal Philips has entered into an agreement to acquire SpectraWAVE, Inc., an innovator in enhanced vascular imaging (EVI) of coronary arteries, angiography-based physiology assessments and the use of AI in medical imaging3. SpectraWAVE’s intravascular imaging and physiological assessment technologies provide solutions for treating patients with coronary artery disease, the most frequent type of heart disease, affecting 300+ million people worldwide4.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now